RPHM
Reneo Pharmaceuticals, Inc.
7.00
USD
This page is just a preview of the data found in TrendSpider’s full version
Reneo Pharmaceuticals, Inc. stock is up 9.38% since 30 days ago. The next earnings date is Mar 25, 2024. The company has had above-average volume in the last 30 days. Its seasonality going into this month shows a chance of a green month, as 100% of the previous 2 December’s closed higher than November. In the last 10 Unusual Options Trades, there were 6 CALLs, 4 PUTs. 100% of analysts rate it a buy.
| Date & Time | Expiration Date | Strike Price | Trade Type | Size | Open Interest |
|---|---|---|---|---|---|
| 06 Dec 14:49 | 15 Dec, 2023 | 12.50 | 323 | ||
| 06 Dec 15:35 | 19 Jan, 2024 | 15.00 | 10891 | ||
| 06 Dec 15:35 | 16 Feb, 2024 | 10.00 | 11 | ||
| 06 Dec 16:53 | 15 Dec, 2023 | 5.00 | 4412 | ||
| 06 Dec 17:32 | 19 Jan, 2024 | 15.00 | 10891 | ||
| 06 Dec 19:21 | 19 Jan, 2024 | 10.00 | 5312 | ||
| 06 Dec 19:21 | 19 Jan, 2024 | 15.00 | 10891 | ||
| 08 Dec 14:42 | 15 Dec, 2023 | 10.00 | 5 | ||
| 08 Dec 14:54 | 15 Dec, 2023 | 7.50 | 90 | ||
| 08 Dec 14:56 | 15 Dec, 2023 | 5.00 | 4840 |
Reneo Pharmaceuticals, Inc. focuses on the development of therapies for patients with rare genetic mitochondrial diseases. It develops REN001, a selective peroxisome proliferator-activated receptor delta agonist, which is in Phase IIb clinical trial.
